Neoleukin Therapeutics, Inc.
NLTX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75,144 | -$57,557 | -$60,692 | -$33,277 |
| Dep. & Amort. | $3,247 | $2,612 | $2,277 | $1,821 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,320 | $8,829 | $11,557 | $5,622 |
| Change in WC | $0 | $885 | -$700 | $966 |
| Other Non-Cash | -$7,026 | -$376 | $0 | $293 |
| Operating Cash Flow | -$70,603 | -$45,607 | -$47,558 | -$24,575 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$808 | -$1,110 | -$3,263 | -$2,219 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$198,453 | -$107,524 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $49,500 | $0 | $0 |
| Other Inv. Act. | $74,000 | $0 | $0 | $0 |
| Investing Cash Flow | -$125,261 | -$59,134 | -$3,263 | -$2,219 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $134 | $0 | $71,675 |
| Stock Repurch. | $0 | $82 | $372 | $199 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $184,071 | $161 | $732 | $77,135 |
| Financing Cash Flow | $184,071 | $161 | $732 | $77,135 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,793 | -$104,580 | -$50,089 | $50,341 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $148,718 | $143,345 | $193,434 | $143,093 |
| End Cash | $136,925 | $38,765 | $143,345 | $193,434 |
| Free Cash Flow | -$71,411 | -$46,717 | -$50,821 | -$26,794 |